Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lateralizing value of transient hypofrontality during Wada's test

N P Verma1, C Rangnathan, D R Fuerst

  • 1Epilepsy Center of Michigan, Wayne State University School of Medicine, Detroit.

Seizure
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial functioning of children with learning disabilities at three age levels.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2015
Same author

CMT1X phenotypes represent loss of GJB1 gene function.

Neurology·2007
Same author

Reliability and validity of the CMT neuropathy score as a measure of disability.

Neurology·2005
Same author

Patient motivation for laser in situ keratomileusis in the State of Bihar.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2004
Same author

Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.

Brain : a journal of neurology·2000
Same author

Explicit memory in pregnant women.

American journal of obstetrics and gynecology·1998
Same journal

Development of a standard for epilepsy semiology and semiological description dataset: a modified Delphi study.

Seizure·2026
Same journal

UNC13A-related neurodevelopmental disorders in children: epilepsy phenotypes and antiseizure medication response.

Seizure·2026
Same journal

Switching from oxcarbazepine to eslicarbazepine in patients with focal epilepsy: A systematic review and single-arm meta-analysis.

Seizure·2026
Same journal

Efficacy, tolerability, and EEG lateralization-based predictors of neuropsychiatric adverse events in pediatric SeLECTS treated with perampanel monotherapy.

Seizure·2026
Same journal

Cross-cultural validation of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) in Chinese-speaking people with epilepsy.

Seizure·2026
Same journal

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
See all related articles

Transient hypofrontality occurred in 5/22 patients after Wada testing, specifically when the side contralateral to the seizure focus was injected. This finding may indicate lateralizing value in epilepsy diagnosis.

Area of Science:

  • Neurology
  • Neuropsychology
  • Epilepsy Research

Background:

  • The Wada test is crucial for lateralizing brain function in epilepsy surgery candidates.
  • Transient hypofrontality is a potential neurophysiological phenomenon observed during Wada testing.

Purpose of the Study:

  • To investigate the occurrence and potential lateralizing value of transient hypofrontality following Wada testing.
  • To explore the relationship between seizure focus and the development of transient hypofrontality.

Main Methods:

  • Retrospective analysis of 22 patients undergoing Wada testing.
  • Correlation of transient hypofrontality with the injection side relative to the seizure focus identified by ictal recordings.

Main Results:

Related Experiment Videos

  • Five out of 22 subjects (22.7%) developed transient hypofrontality.
  • This phenomenon consistently occurred after injection of the cerebral hemisphere contralateral to the established seizure focus.

Conclusions:

  • Transient hypofrontality following Wada testing may serve as a useful lateralizing sign in epilepsy.
  • The mechanism might involve pharmacological inactivation of the contralateral frontal lobe combined with pre-existing ipsilateral frontal lobe compromise.